Signed · Poland · Pharma and biotech
Abacus Medicine Group agrees to acquire Delfarma.
Copenhagen-based parallel distributor Abacus Medicine Group agreed on 14 September 2026 to buy Delfarma, a Polish parallel importer of medicines with its own repackaging production. The deal marks the group's entry into Poland and needs Polish competition clearance, expected within six to eight weeks. It was signed on 14 September 2026. It had not completed by 28 October 2026.
Signing 14 September 2026
- Buyer
- Abacus Medicine Group ·Copenhagen, Denmark
- Target
- Delfarma ·Lodz, Poland
- Type
- Acquisition
- Announced
- 14 September 2026
- Signed
- 14 September 2026
- Value
- Not disclosed
- People
- Not stated in the release
- Last checked
- 28 October 2026
The people side in Poland
- In a transfer of a workplace or part of it, the new employer becomes party to existing employment relationships by law, and the transfer is no ground for notice of termination. Labour Code (Kodeks pracy), article 23(1) sections 1 and 6
- Old and new employer inform their company unions at least 30 days before the planned transfer, and negotiate for up to 30 days on planned changes to employment terms. Trade Unions Act (ustawa o związkach zawodowych), article 26(1)
- Where no company union operates, both employers inform employees, on paper or electronically, at least 30 days before the transfer. Employees may resign on seven days' notice within two months of it. Labour Code (Kodeks pracy), article 23(1) sections 3 and 4
- Above EUR 1 billion combined worldwide or EUR 50 million Polish turnover, an acquisition of control waits for UOKiK clearance, unless the target's Polish turnover stayed within EUR 10 million in both prior years. Competition and Consumer Protection Act, articles 13, 14 and 97
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
Octagon runs payroll in Poland for international buyers, with or without a local entity of their own.
- Buyer press release, 14 September 2026 (primary source)
Related deals
- 10 Nov
Andersen Group Inc.to
Andersen Polanddeal page: Andersen Group agrees to acquire Andersen PolandSigned
not statedSigningDay 100 - 6 Nov
Dipharma SAto
LogixX Pharma Limiteddeal page: Dipharma acquires LogixX PharmaCompleted
not statedSigningDay 100 - 5 Nov
ANI Pharmaceuticals, Inc.to
Egetis Therapeutics AB (publ)deal page: ANI Pharmaceuticals to acquire Egetis TherapeuticsAnnounced
not statedSigningDay 100 - 3 Nov
HRV Global Life Sciences Private Limited (through New Horizon Pharma B.V.)to
Phatebo GmbHdeal page: HRV Pharma agrees to acquire PhateboSigned
not statedSigningDay 100